Sponsor Pipeline

Actuate Therapeutics Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
7
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-20 NCT07714395 Evaluate Preliminary Anti-tumor Activity of Elraglusib in Adult Participants With… Phase 1/2 Not Yet Recruiting
Active Trials by Phase
Phase 2
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT03678883 9-ING-41 in Patients With Advanced Cancers Cancer Active, Not Recruiting
Phase 1/2
NCT07714395 Evaluate Preliminary Anti-tumor Activity of Elraglusib in Adult Participants With… Advanced Malignant Solid Tumor Not Yet Recruiting
Disease Areas
Breast Cancer (1) Pancreatic Cancer (1) Kidney Cancer (1) Glioma (1) Leukemia (1) Non-Hodgkin Lymphoma (1) Sarcoma (1)
Get alerts when Actuate Therapeutics Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free